Evidence map›Paper›PMID 9632818›Full record

ArticleMolecular and cellular biology1998

Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain.

R C Fisher, M C Olson, J M Pongubala, J M Perkel, M L Atchison, E W Scott, M C Simon

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Blood pressure homeostasis is maintained by a P311-TGF-β axis.The Journal of clinical investigation · 2013
    Article
  6. Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells.Journal of immunology (Baltimore, Md. : 1950) · 2012
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Evolution of hematopoiesis: Three members of the PU.1 transcription factor family in a cartilaginous fish, Raja eglanteria.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

R C FisherInstitute for Human Gene Therapy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
M C Olson
J M Pongubala
J M Perkel
M L Atchison
E W Scott
M C Simon
University of Pennsylvania · USHoward Hughes Medical Institute · USHuman Gene Therapy Research Institute · US

Funding

Analysis of PU.1 Function in HematopoiesisR01CA072769 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SCOTT, EDWARD W · 1997 to 2007
$2.0M
DEVELOPMENTAL CONTROL OF IMMUNOGLOBULIN TRANSCRIPTIONR01GM042415 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI ATCHISON, MICHAEL L. · 1989 to 2005
$1.7M
SPI-1 AND SPI-B AND HEMATOPOIETIC DEVELOPMENTR01HL052094 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SIMON, M. CELESTE · 1994 to 2002
$542k
NCI NIH HHS CA72769NCI NIH HHS R01 CA072769NHLBI NIH HHS HL52094NIGMS NIH HHS R01 GM042415
6 · The paper itself

Abstract

Gene targeting of transcription factor PU.1 results in an early block to fetal hematopoiesis, with no detectable lymphoid or myeloid cells produced in mouse embryos. Furthermore, PU.1(-/-) embryonic stem (ES) cells fail to differentiate into Mac-1(+) and F4/80(+) macrophages in vitro. We have previously shown that a PU.1 transgene under the control of its own promoter restores the ability of PU. 1(-/-) ES cells to differentiate into macrophages. In this study, we take advantage of our PU.1(-/-) ES cell rescue system to genetically test which previously identified PU.1 functional domains are necessary for the development of mature macrophages. PU.1 functional domains include multiple N-terminal acidic and glutamine-rich transactivation domains, a PEST domain, several serine phosphorylation sites, and a C-terminal Ets DNA binding domain, all delineated and characterized by using standard biochemical and transactivational assays. By using the production of mature macrophages as a functional readout in our assay system, we have established that the glutamine-rich transactivation domain, a portion of the PEST domain, and the DNA binding domain are required for myelopoiesis. Deletion of three acidic domains, which exhibit potent transactivation potential in vitro, had no effect on the ability of PU.1 to promote macrophage development. Furthermore, mutagenesis of four independent sites of serine phosphorylation also had no effect on myelopoiesis. Collectively, our results indicate that PU.1 interacts with important regulatory proteins during macrophage development via the glutamine-rich and PEST domains. The PU.1(-/-) ES cell rescue system represents a powerful, in vitro strategy to functionally map domains of PU.1 essential for normal hematopoiesis and the generation of mature macrophages.

Indexed as

Transcriptional Activation3T3 CellsAnimalsBinding SitesCell DifferentiationGlutamineHumansMacrophagesMiceProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Trans-ActivatorsGlutamineProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Trans-Activators

Identifiers

PMID9632818
PMCPMC109018
OpenAlexW2122167039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.